MACROGENICS INC — Director's Dealing 2017

Feb 8, 2017

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2016-12-31

Reporting Person: Wigginton Jon Marc (Sr VP, Clinical Dev. & CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-03	Common Stock	S	10000	$29.34	Disposed	30000	Direct

Footnotes

F1: Due to clerical error, the amount of securities beneficially owned after the transaction on 10/3/16 and reported on a Form 4 on 10/19/16, was incorrect. The corrected amount includes 30,000 Restricted Stock Units (RSU) acquired on 2/25/16 which vest on 2/25/18.